Creating Harmonized Food Safety Processes Through Integration

June 5, 2018

The Food and Beverage industry is increasingly adapting to the Global Food Safety Initiative (GFSI) as its “stamp” of high quality and safety. In fact, many leading organizations today will only work with GFSI compliant suppliers. The GFSI-benchmarked food safety schemes SQF, BRC and IFS for example coupled with regulatory oversight are driving organizations to seek methods of enhancing visibility into their quality and safety operations. An automated Food Safety Management System (FSMS) is one of these methods.

Spotlight

Amplycell

Ever had a promising cell line which just did not perform ? A cell line which does not produce enough, or long enough? Amplycell is a biotech service company of which mission is to optimize recombinant protein and monoclonal antibody productions for Diagnostic and Pharmaceutical firms.

OTHER WHITEPAPERS
news image

BIOTECHNOLOGY UPDATE

whitePaper | April 24, 2022

The Global Forum on Biotechnology, established in 2010, is one of 15 Global Fora created by OECD Committees. Global Fora are not official OECD bodiesbut are best described as broad.

Read More
news image

Three Trends to Watch in Life Sciences

whitePaper | June 10, 2022

Healthcare is changing rapidly. Companies who provide products and services to hospitals and physicians will need to adjust their operations to change.

Read More
news image

IoT To The Rescue For Biotech & Pharma Manufacturing

whitePaper | April 7, 2020

The Internet of Things (IoT) could not be timelier for biotech/pharma. With fierce cost pressures, the push for value-based outcomes, and the need for flexible manufacturing solutions, the IoT is the much-needed shot in the arm to bring about transformational change. Sensors, actuators, and devices (“things”) embedded in production equipment and networked through computer systems can generate an enormous amount of data. The data can be mined for insights and opportunities to drive production efficiency, automate monitoring and controlling functions, and enable flexible manufacturing systems.

Read More
news image

Bispecific Antibodies - CMC Considerations

whitePaper | December 16, 2022

Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains.

Read More
news image

Optimizing Freeze-Thaw Processes for Cell and Gene Therapy Commercialization

whitePaper | June 23, 2022

Cell and gene therapies require both efficient and reliable freeze-thaw systems. Building the most effective system depends on selecting the right materials and instruments.

Read More
news image

The A to Z of microarrays evolution of a revolutionary solution

whitePaper | May 27, 2023

The Human Genome Project was a monumental effort over more than a decade to determine the human DNA sequence and analyze genetic variation among individuals. The hope was that, armed with this understanding, phenotypic differences would be explainable by genetic variation, and health benefits could follow.

Read More

Spotlight

Amplycell

Ever had a promising cell line which just did not perform ? A cell line which does not produce enough, or long enough? Amplycell is a biotech service company of which mission is to optimize recombinant protein and monoclonal antibody productions for Diagnostic and Pharmaceutical firms.

Events